Return to homepagePandemic Pact

Implications of COVID-19 for AMR and antimicrobial stewardship in China and other LMIC settings

  • Funded by British Society for Antimicrobial Chemotherapy (BSAC)
  • Total publications:2 publications

Grant number: BSAC-COVID-72

Grant search

Key facts

  • Disease

    COVID-19

  • Known Financial Commitments (USD)

    $98,697.75

  • Funder

    British Society for Antimicrobial Chemotherapy (BSAC)

  • Principal Investigator

    Helen Lambert, Esmita Charani, Wenjuan Cong, Luwen Shi, Haishaerjiang Wushouer, Guiqing Yao
    …

  • Research Location

    United Kingdom

  • Lead Research Institution

    Population Health Sciences, University of Bristol

  • Research Priority Alignment

    N/A

  • Research Category

    Secondary impacts of disease, response & control measures

  • Research Subcategory

    Indirect health impacts

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

Prevalence of antibiotic prescribing in COVID-19 patients in China and other low- and middle-income countries during the pandemic (December 2019-March 2021): a systematic review and meta-analysis.

Antibiotic Use and Bacterial Infection in COVID-19 Patients in the Second Phase of the SARS-CoV-2 Pandemic: A Scoping Review.